These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 1070769)
1. [Effects of BCG in the treatment and prevention of neoplasms]. Willms K Rev Latinoam Microbiol; 1976; 18(1):11-7. PubMed ID: 1070769 [No Abstract] [Full Text] [Related]
2. [Cancer immunotherapy with BCG and its derivatives--clinical trials (author's transl)]. Ogura T Kekkaku; 1980 Aug; 55(8):359-63. PubMed ID: 6999203 [No Abstract] [Full Text] [Related]
3. [Immunotherapy of cancer with BCG]. Rieche K; Schneeweiss U; Gummel H Dtsch Gesundheitsw; 1970 Aug; 25(34):1581-5. PubMed ID: 4926378 [No Abstract] [Full Text] [Related]
4. BCG and cancer prevention. Shimkin MB West J Med; 1975 Feb; 122(2):185. PubMed ID: 234658 [No Abstract] [Full Text] [Related]
5. BCG: A note of caution. Bluming AZ N Engl J Med; 1973 Oct; 289(16):860-1. PubMed ID: 4763431 [No Abstract] [Full Text] [Related]
6. [Treatment of the complications occurring in BCG vaccine immunotherapy of patients with malignant neoplasms]. Grigorovich NA; Risina DIa; Nodel'son SE Vopr Onkol; 1984; 30(7):102-6. PubMed ID: 6464396 [TBL] [Abstract][Full Text] [Related]
7. [Immunotherapy of cancers]. Longpré B; Pleszczynski M Union Med Can; 1978 May; 107(5):485-91. PubMed ID: 664095 [No Abstract] [Full Text] [Related]
8. [BCG and immunotherapy for tumors. Prevention of adverse effects of BCG vaccination]. Lugosi L Orv Hetil; 1972 Mar; 113(13):757-9. PubMed ID: 5021351 [No Abstract] [Full Text] [Related]
9. [Polyarthritis as a rare complication in BCG immunoprophylaxis of urinary bladder cancer]. Varentsov GI; Zakhmatov IuM; Kornev AI; Otvetchikov IN Urologiia; 1999; (5):29-30. PubMed ID: 11150151 [TBL] [Abstract][Full Text] [Related]
14. BCG in cancer and leukemia treatment and prophylaxis-A review. Rosenthal SR J Med; 1975; 6(3-4):193-212. PubMed ID: 1104732 [TBL] [Abstract][Full Text] [Related]
15. Non specific immunotherapy with B.C.G. in superficial bladder cancer: an overview. Van der Meijden AP In Vivo; 1991; 5(6):599-604. PubMed ID: 1810445 [TBL] [Abstract][Full Text] [Related]
16. BCG immunotherapy by the time technique: the nurses's role. Carroll RM Cancer Nurs; 1978 Jun; 1(3):241-6. PubMed ID: 248307 [No Abstract] [Full Text] [Related]
18. Risk-adapted use of intravesical immunotherapy. Braasch MR; Böhle A; O'Donnell MA BJU Int; 2008 Nov; 102(9 Pt B):1254-64. PubMed ID: 19035890 [No Abstract] [Full Text] [Related]
19. [Systemic BCG reactions after intravesical BCG therapy. A report of four cases]. Sfaxi M; Langar H; Ouni A; Riahi Y; El Aidli S; Daghfous R; Ben Abdeladhim A; Chébil M Therapie; 2008; 63(1):43-7. PubMed ID: 18387275 [TBL] [Abstract][Full Text] [Related]
20. [A review on mechanism of anti-tumor action of BCG (author's transl)]. Tokunaga T Kekkaku; 1980 Aug; 55(8):351-7. PubMed ID: 6999202 [No Abstract] [Full Text] [Related] [Next] [New Search]